about
PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cellsDetecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.MicroRNA signatures differentiate melanoma subtypes.Phosphoproteomic screen identifies potential therapeutic targets in melanoma.Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.
P4510
description
Zelllinie
@de
ceall-líne
@ga
cell line
@en
cellijn van een Homo sapiens
@nl
lignée cellulaire
@fr
name
YUKIM
@de
YUKIM
@en
YUKIM
@fr
YUKIM
@ga
YUKIM
@nl
type
label
YUKIM
@de
YUKIM
@en
YUKIM
@fr
YUKIM
@ga
YUKIM
@nl
prefLabel
YUKIM
@de
YUKIM
@en
YUKIM
@fr
YUKIM
@ga
YUKIM
@nl